Matterworks, Inc. develops AI-powered tools designed to extract insights from biological data, supporting work across therapeutic discovery, drug development, clinical development, biomanufacturing, toxicology, and safety assessment. The company's technical expertise spans biology, machine learning, deep learning, bioinformatics, and large-scale data analysis.
The company's main product, Pyxis, is a cloud-based AI platform that guides analysis and helps scientists build models that interpret data into biological insights. Matterworks also develops Large Spectral Models (LSMs) - AI models trained on billions of small molecule, lipid, peptide, and protein spectra across millions of biological contexts, aimed at extracting predictive power from omic data.
Headquartered in Somerville, Massachusetts, Matterworks operates under a flexible hybrid model with team members working both from its office and remotely across various locations. The team draws heavily from scientific backgrounds, with staff experienced in the challenges researchers face when working with complex molecular data.
